Skip to main content
. 2022 Jan 26;9(2):122–131. doi: 10.1002/acn3.51492

Table 3.

Immunosuppressor therapies used for the treatment of drug‐refractory MG, percentage of withdrawal, reasons for withdrawal, and reported side effects.

Immunosuppressor (number of patients) Withdrawal (%) Reasons for withdrawal (%) Side effects
Prednisone (84) 18 (21.4)

6 (33.3) inefficacy

6 (33.3) side effects

6 (33.3) improvement or remission

1 High blood pressure

1 Diabetes mellitus

1 High blood pressure + diabetes mellitus

1 Osteopenia

1 Compulsion

1 Weight gain

Azathioprine (70) 63 (90)

40 (63.5) inefficacy

22 (34.9) side effects

1 (1.6) inefficacy and side effects

5 Hepatotoxicity

5 Abdominal pain

4 Anemia

3 Allergy

1 Pancytopenia

1 Leucopenia

1 Arthralgia

3 Unknown

Mycophenolate Mofetil (57) 43 (75.4)

32 (74.4) inefficacy

8 (18.6) side effects

3 (7.0) desire for pregnancy

2 Abdominal pain

2 Hepatotoxicity

1 Diarrhea

1 Abdominal pain and diarrhea

1 Pancytopenia

1 Unknown

Cyclosporine (56) 45 (80.4)

21 (46.7) inefficacy

21 (46.7) side effects

2 (4.4) inefficacy and side effects

1 (2.2) desire for pregnancy

10 Nephrotoxicity

4 Abdominal pain

2 High blood pressure and headache

1 Hepatotoxicity

1 Hypertrichosis

1 Gum hyperplasia

1 Tremor

1 Anemia and leucopenia

2 Unknown

Tacrolimus (33) 17 (51.5)

8 (47.1) inefficacy

7 (41.2) side effects

2 (11.8) remission

2 Nausea and vomits

1 Skin rash

1 Alopecia

1 Hyperglycemia

1 Vision loss

1 Unknown

Rituximab (40) 35 (87.5)

21 (60.0) inefficacy

2 (5.7) inefficacy and side effects

13 (37.1) remission

1 Psoriasis exacerbation

1 Progressive multifocal leukoencephalopathy

Methotrexate (6) 5 (83.3)

2 (40) inefficacy

1 (20) side effects

2 (40) remission

1 Abdominal pain
Cyclophosphamide (7) 7 (100)

3 (42.9) inefficacy

1 (14.3) inefficacy and side effects

3 (42.9) remission

1 Toxic organizing pneumonia

MG, myasthenia gravis.